Shopping Cart
- Remove All
- Your shopping cart is currently empty
Caloxin 2A1 TFA is a novel PM Ca2+ pump inhibitor. It inhibits human red blood cell Ca2+-Mg2+-ATPase, blocking Ca2+ dependent formation of a 140-kDa acid-stable acylphosphate.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $42 | In Stock | |
5 mg | $91 | In Stock | |
10 mg | $148 | In Stock | |
25 mg | $297 | In Stock | |
50 mg | $448 | In Stock |
Description | Caloxin 2A1 TFA is a novel PM Ca2+ pump inhibitor. It inhibits human red blood cell Ca2+-Mg2+-ATPase, blocking Ca2+ dependent formation of a 140-kDa acid-stable acylphosphate. |
In vitro | Caloxin 2A1 TFA showed inhibition of Ca²⁺-Mg²⁺-ATPase in human erythrocytes but had no significant effect on basal Mg²⁺-ATPase and Na²⁺-K⁺-ATPase activity in ghost cells and in the sarcoplasmic reticulum of skeletal muscle. In addition, Caloxin 2A1 TFA blocked the Ca²⁺-dependent generation of 140-kDa acid-stabilized acyl phosphate. [1] Caloxin 2A1 TFA promoted the apoptotic process in airway smooth muscle cells (ASMC). [2] |
Molecular Weight | 1592.55 |
Formula | C66H92F3N19O24 |
Storage | keep away from moisture,store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | H2O: 80.00 mg/mL (50.23 mM), Sonication is recommended. ![]() DMSO: 80.00 mg/mL (50.23 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
H2O/DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.